UCB's Global Corporate Website

This section is intended for media and financial analysts

Transparency notification of Wellington Management Company LLP

Participation on 7 February 2011 (according to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings).

Brussels (Belgium), 10 February 2011 – 18:00 PM CET - regulated information - Wellington Management Company, LLP having its registered offices at 280 Congress Street, Boston, MA 02210, United States of America, notified having bought a number of UCB shares with voting rights on February 7, 2011 increasing their shareholding to have it cross the lowest statutory threshold of 3% for notification and is currently holding 5 505 950 shares (on a total number of 183 365 052) representing 3.00% of UCB’s share capital.

For further information
Antje Witte, Investor Relations, UCB
T +32.2.559.9414,
antje.witte@ucb.com

Michael Tuck-Sherman, Investor Relations, UCB
T +32.2.559.9712,
Michael.tuck-sherman@ucb.com

Nancy Nackaerts, External Communications, UCB
M: +32.473.864.414,
nancy.nackaerts@ucb.com

Notes to the editor

About UCB
UCB, Brussels, Belgium (
www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8 000 people in about 40 countries, the company generated revenue of EUR 3.1 billion in 2009. UCB is listed on Euronext Brussels (symbol: UCB).

Forward looking statement
This press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially different from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, effects of future judicial decisions, changes in regulation, exchange rate fluctuations and hiring and retention of employees.

Asset Download

Stay up-to-date on the latest news and information from UCB

Subscribe